Skip to main content

The Process of Blood Pressure Measurement and the Value of Additional Readings

March 24, 2020

History: Blood Pressure Measurement Background Blood pressure is one of the first objective measures used to evaluate risk in life… Read More

Tags: Blood Pressure, Healthcare, Life Insurance, Risk, Underwriting

Rising Mortality Rates: What Insurers Should Know & Consider

March 9, 2020

Bad news for actuaries: according to the latest from the US Journal of the American Medical Association, mortality rates for… Read More

Tags: Drug Test, Life Insurance, Mortality, Underwriting

CRISPR Technology: Implications for the Insurance Industry and Beyond

February 28, 2020

Dr. Steven J. Rigatti, consulting medical director to CRL, discusses the novel use of the CRISPR technique and its potential… Read More

Tags: CRISPR, Crispr Cas9, Dna, Life Insurance, Sickle Cell

Dementia: Causes, Risks, and Potential Prevention

February 18, 2020

Dr. Michael Fulks is a Medical Director for Clinical Reference Laboratory (CRL). He is an expert commentator on core issues… Read More

Tags: Alzheimers, Cardiovascular Disease, Dementia, Life Insurance, Underwriting

Epigenetics: Why the Science is Important & What CRL Needs from You

January 30, 2020

Epigenetic testing is a critical part of CRL’s approach to innovative science. Read below to learn about how epigenetic testing… Read More

Tags: Clinical Research, Epigenetics, Insurance, Laboratory, Life Insurance

The Opioid Crisis, Marijuana Laws, and Life Expectancy in the US

January 8, 2020

Is legalized cannabis the answer to America’s opioid crisis? This provocative question is garnering significant attention from the team at Clinical… Read More

Tags: Drugs, Insurance, Life Insurance, Marijuana Legalization, Opiods

Welcome to the CRL Insurer Services Blog

December 19, 2019

From DNA to insuretech to product development, the world of life insurance is moving and will continue to do so… Read More

Tags: Dna, Insurtech, Life Insurance, Risk Management